Trial Profile
Evaluation of Renal Protection by Imidapril and Irbesartan in Patients with Essential Hypertension.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Jul 2015
Price :
$35
*
At a glance
- Drugs Imidapril (Primary) ; Irbesartan (Primary)
- Indications Essential hypertension
- Focus Pharmacodynamics; Therapeutic Use
- 10 Sep 2009 New trial record